Nemaura Medical Inc. (NMRD)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Mar 4, 2026, 4:00 PM EST
900.00%
Market Cap 40.00
Revenue (ttm) n/a
Net Income (ttm) -10.65M
Shares Out 40.35M
EPS (ttm) -0.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 6,992
Open 0.0002
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta -117.28
RSI 48.06
Earnings Date Feb 11, 2026

About Nemaura Medical

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Employees 36
Stock Exchange OTCMKTS
Ticker Symbol NMRD
Full Company Profile

Financial Performance

In fiscal year 2023, Nemaura Medical's revenue was $77,044, a decrease of -84.71% compared to the previous year's $503,906. Losses were -$14.14 million, 1.85% more than in 2022.

Financial Statements

News

There is no news available yet.